Apr 8 |
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
|
Apr 3 |
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
|
Mar 27 |
The 7 Best Penny Stocks to Buy in Q2 2024
|
Mar 26 |
Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks
|
Mar 19 |
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
|
Mar 11 |
AbCellera gains on antibody collaboration with Biogen
|
Mar 11 |
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
|
Mar 5 |
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
|
Feb 29 |
After losing 38% in the past year, AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners must be relieved by the recent gain
|
Feb 28 |
AbCellera: Victim Of Its Own Success
|